EVH - EVH エボレント・ヘルス （）

Evolent Health (EVH) is scheduled to announce Q1 earnings results on Wednesday, May 3rd, after market close.The consensus EPS Estimate is $0.19 (+58.3% Y/Y) and the consensus…

Evolent began life as a software developer but 2018 acquisition of New Century Health has seen it shift into specialty care provision. Click here to read why EVH stock is a Buy.

Company to Also Host an Investor Day on Tuesday, May 23 WASHINGTON, April 17, 2023 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven specialty clinical solutions to payers and providers, today announced it will release its first quarter 2023…

Evolent Health, Inc - Consensus Indicates Potential 38.5% Upside

https://www.investing.com/news/pro/evolent-health-pt-raised-to-63-at-cowen-432SI-3012686

Evolent Health, Inc found using ticker (EVH) have now 8 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 57 and 32 and has a mean target at 42.25. Now with the previous closing price of 28.66 this indicates there is a potential upside of 47.4%. The 50 day moving average now sits at 29.85 while the 200 day moving average is 31.04. The company has a market capitalisation of $2,759m. You can visit the company''s website by visiting: https://www.evolenthealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EVH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,068m based on the market concensus. Evolent Health, a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management.

Evolent Health, Inc found using ticker (EVH) now have 8 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 57 and 32 calculating the average target price we see 40.88. Now with the previous closing price of 26.79 this now indicates there is a potential upside of 52.6%. The 50 day moving average now sits at 31.63 and the 200 day MA is 30.87. The company has a market cap of $2,780m. You can visit the company''s website by visiting: https://www.evolenthealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EVH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,242m based on the market concensus. Evolent Health, a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions.

Evolent Health''s shares have seen a huge move higher on the back of a substantial deal. Click here to find out why the latest deal looks interesting.

Thursday after close, Evolent Health Inc (NYSE: EVH ) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene Corporation (NYSE: CNC ), for $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance . William Blair is positive on the acquisition and believes this is consistent with management''s prior commentary that Evolent would consider strategic assets … Full story available on Benzinga.com

Gainers PaxMedica, Inc. (NASDAQ: PXMD ) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. Satixfy Communications Ltd. (NYSE: SATX ) rose 53.2% to $79.20. 1847 Holdings LLC (NYSE: EFSH ) gained 27.3% to $2.0252. 1847 Holdings recently posted Q3 sales of $14.47 million. IVERIC bio, Inc. (NASDAQ: ISEE ) shares surged 25% to $21.54 after the company announced the FDA has granted breakthrough therapy designation for avacincaptad pegol for geographic atrophy. Clearfield, Inc. (NASDAQ: CLFD ) climbed 24.1% to $115.45 after the company reported better-than-expected Q4 results. Yatra Online, Inc. (NASDAQ: YTRA ) shares jumped 24.1% to $2.6299. Yatra Online''s Indian subsidiary, Yatra Online Limited, received the final observation from the Securities and Exchange Board of India. The company also announced that it will report its Q2 financial results on Tuesday, November 29, 2022. Conformis, Inc. (NASDAQ: CFMS ) gained 23.6% to $1.9540.

Evolent Health, Inc found using ticker (EVH) now have 8 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 57 and 32 calculating the average target price we see 40.88. Now with the previous closing price of 26.79 this now indicates there is a potential upside of 52.6%. The 50 day moving average now sits at 31.63 and the 200 day MA is 30.87. The company has a market cap of $2,780m. You can visit the company''s website by visiting: https://www.evolenthealth.com [stock_market_widget type="chart" template="basic" color="green" assets="EVH" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,242m based on the market concensus. Evolent Health, a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions.

Evolent Health''s shares have seen a huge move higher on the back of a substantial deal. Click here to find out why the latest deal looks interesting.

Thursday after close, Evolent Health Inc (NYSE: EVH ) agreed to acquire Magellan Specialty Health, the specialty benefit management organization owned by Centene Corporation (NYSE: CNC ), for $650 million at the close plus additional contingent consideration of up to $150 million based on 2023 performance . William Blair is positive on the acquisition and believes this is consistent with management''s prior commentary that Evolent would consider strategic assets … Full story available on Benzinga.com

Gainers PaxMedica, Inc. (NASDAQ: PXMD ) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. Satixfy Communications Ltd. (NYSE: SATX ) rose 53.2% to $79.20. 1847 Holdings LLC (NYSE: EFSH ) gained 27.3% to $2.0252. 1847 Holdings recently posted Q3 sales of $14.47 million. IVERIC bio, Inc. (NASDAQ: ISEE ) shares surged 25% to $21.54 after the company announced the FDA has granted breakthrough therapy designation for avacincaptad pegol for geographic atrophy. Clearfield, Inc. (NASDAQ: CLFD ) climbed 24.1% to $115.45 after the company reported better-than-expected Q4 results. Yatra Online, Inc. (NASDAQ: YTRA ) shares jumped 24.1% to $2.6299. Yatra Online''s Indian subsidiary, Yatra Online Limited, received the final observation from the Securities and Exchange Board of India. The company also announced that it will report its Q2 financial results on Tuesday, November 29, 2022. Conformis, Inc. (NASDAQ: CFMS ) gained 23.6% to $1.9540.

Investors are applauding the clinical and administrative services company''s latest acquisition.